These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25733027)

  • 61. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
    Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
    Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction.
    Liu F; Zhuang X; Yang C; Li Z; Xiong S; Zhang Z; Li J; Lu C; Zhang Z
    Biopharm Drug Dispos; 2014 Jul; 35(5):296-307. PubMed ID: 24647883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE
    Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
    Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preclinical
    Grillo MP; Markova S; Evanchik M; Trellu M; Moliner P; Brun P; Perreard-Dumaine A; Vicat P; Driscoll JP; Carlson TJ
    Xenobiotica; 2021 Feb; 51(2):222-238. PubMed ID: 33078965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
    Mandagere AK; Thompson TN; Hwang KK
    J Med Chem; 2002 Jan; 45(2):304-11. PubMed ID: 11784135
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemotherapeutics overcoming nonsense mutation-associated genetic diseases: medicinal chemistry of negamycin.
    Taguchi A; Hamada K; Hayashi Y
    J Antibiot (Tokyo); 2018 Feb; 71(2):205-214. PubMed ID: 28951602
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gender-Dependent Pharmacokinetics of Veratramine in Rats: In Vivo and In Vitro Evidence.
    Lyu C; Zhang Y; Zhou W; Zhang S; Kou F; Wei H; Zhang N; Zuo Z
    AAPS J; 2016 Mar; 18(2):432-44. PubMed ID: 26791530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Asymmetric synthesis of (+)-negamycin.
    Jain RP; Williams RM
    J Org Chem; 2002 Sep; 67(18):6361-5. PubMed ID: 12201754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings.
    Valicherla GR; Katekar RA; Dadge S; Riyazuddin M; Syed AA; Singh SK; Husain A; Wahajuddin M; Gayen JR
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056659
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Illicit Transport via Dipeptide Transporter Dpp is Irrelevant to the Efficacy of Negamycin in Mouse Thigh Models of Escherichia coli Infection.
    McKinney DC; Bezdenejnih-Snyder N; Farrington K; Guo J; McLaughlin RE; Ruvinsky AM; Singh R; Basarab GS; Narayan S; Buurman ET
    ACS Infect Dis; 2015 May; 1(5):222-30. PubMed ID: 27622650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.
    Fouché M; Schäfer M; Berghausen J; Desrayaud S; Blatter M; Piéchon P; Dix I; Martin Garcia A; Roth HJ
    ChemMedChem; 2016 May; 11(10):1048-59. PubMed ID: 27154275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products.
    Bockus AT; Lexa KW; Pye CR; Kalgutkar AS; Gardner JW; Hund KC; Hewitt WM; Schwochert JA; Glassey E; Price DA; Mathiowetz AM; Liras S; Jacobson MP; Lokey RS
    J Med Chem; 2015 Jun; 58(11):4581-9. PubMed ID: 25950816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer's disease.
    Leithold LH; Jiang N; Post J; Niemietz N; Schartmann E; Ziehm T; Kutzsche J; Shah NJ; Breitkreutz J; Langen KJ; Willuweit A; Willbold D
    Eur J Pharm Sci; 2016 Jun; 89():31-8. PubMed ID: 27086111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.